Victory Capital Management’s Vaxart VXRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-26,499
Closed -$12K 2558
2025
Q2
$12K Sell
26,499
-644
-2% -$280 ﹤0.01% 2467
2025
Q1
$11K Sell
27,143
-745
-3% -$478 ﹤0.01% 2448
2024
Q4
$18.5K Sell
27,888
-712
-2% -$495 ﹤0.01% 2451
2024
Q3
$24.3K Buy
28,600
+6,044
+27% +$4.62K ﹤0.01% 2429
2024
Q2
$15.1K Buy
+22,556
New +$18.7K ﹤0.01% 2448
2023
Q4
Sell
-16,532
Closed -$12.5K 2650
2023
Q3
$12.5K Buy
16,532
+2,305
+16% +$1.75K ﹤0.01% 2475
2023
Q2
$10.4K Sell
14,227
-330
-2% -$307 ﹤0.01% 2482
2023
Q1
$11K Buy
14,557
+343
+2% +$319 ﹤0.01% 2542
2022
Q4
$13.7K Sell
14,214
-5
-0% -$7 ﹤0.01% 2531
2022
Q3
$31K Sell
14,219
-2,479
-15% -$8.55K ﹤0.01% 2601
2022
Q2
$58K Sell
16,698
-28
-0.2% -$105 ﹤0.01% 2536
2022
Q1
$58K Sell
16,726
-435
-3% -$2.2K ﹤0.01% 2584
2021
Q4
$108K Sell
17,161
-35,565
-67% -$243K ﹤0.01% 2565
2021
Q3
$419K Sell
52,726
-886
-2% -$7.29K ﹤0.01% 2258
2021
Q2
$402K Sell
53,612
-408
-0.8% -$2.85K ﹤0.01% 2306
2021
Q1
$327K Buy
54,020
+259
+0.5% +$1.99K ﹤0.01% 2367
2020
Q4
$307K Buy
53,761
+36,921
+219% +$235K ﹤0.01% 2276
2020
Q3
$112K Buy
16,840
+4,865
+41% +$43.3K ﹤0.01% 2341
2020
Q2
$106K Sell
11,975
-11,307
-49% -$32.5K ﹤0.01% 2351
2020
Q1
$42K Buy
+23,282
New +$29.6K ﹤0.01% 2846
2019
Q4
Sell
-2,165
Closed -$1K 3280
2019
Q3
$1K Buy
+2,165
New +$1.41K ﹤0.01% 3724

Other funds holding VXRT

Victory Capital Management's VXRT Position: Q3 2025 in Review

Victory Capital Management sold out of Vaxart (VXRT) in Q3 2025, closing a stake of 26,499 shares — an estimated $12K sold.

Victory Capital Management first reported a position in VXRT in Q3 2019 and held it in 21 quarters. The position peaked at $419K in Q3 2021. 17 funds tracked by Wall St. Rank hold VXRT as of Q3 2025.

  • Victory Capital Management reported no remaining Vaxart position as of Q3 2025 after selling out during the quarter.
  • Victory Capital Management sold 26,499 Vaxart shares in Q3 2025, an estimated $12K.
  • Victory Capital Management first reported a position in Vaxart in Q3 2019 and held it in 21 quarters.
  • Victory Capital Management's Vaxart position peaked at $419K in Q3 2021.
  • 17 funds tracked by Wall St. Rank held Vaxart as of Q3 2025.

Based on Victory Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.